Vicore Pharma Holding AB (publ) (VCRE)
NASDAQ: VCRE · Real-Time Price · USD
8.82
+0.16 (1.85%)
At close: Oct 8, 2026, 4:00 PM EDT
8.65
-0.17 (-1.93%)
After-hours: Oct 8, 2026, 4:10 PM EDT
Vicore Pharma Holding AB Market Cap
Vicore Pharma Holding AB has a market cap or net worth of $244.88 million as of October 8, 2026. Its market cap has decreased by 23.45% in one year.
Market Cap
244.88M
Enterprise Value
154.33M
1-Year Change
-23.45%
Global Rank
n/a
Country Rank
n/a
Category
ChartMarket Cap Chart
Since December 10, 2015, Vicore Pharma Holding AB's market cap has increased from $10.33M to $244.88M, an increase of 2,270.44%. That is a compound annual growth rate of 33.93%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 8, 2026 | 244.88M | -29.25% |
| Dec 30, 2025 | 346.13M | 92.86% |
| Dec 30, 2024 | 179.47M | 14.25% |
| Dec 29, 2023 | 157.08M | 11.76% |
| Dec 30, 2022 | 140.55M | 27.27% |
| Dec 30, 2021 | 110.43M | -52.45% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Bicycle Therapeutics | 265.27M |
| Palisade Bio | 259.66M |
| Zentalis Pharmaceuticals | 252.77M |
| Upstream Bio | 251.40M |
| AC Immune | 250.56M |
| Camp4 Therapeutics | 248.50M |
| Immuneering | 247.79M |
| Sol-Gel Technologies | 247.65M |